Tiotropium [clinicaltrials_resource:17b37513b438cefbf8247a55601652f1]
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00106821]High Dose Trial in COPD [clinicaltrials:NCT00128440]Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00134979]Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED) [clinicaltrials:NCT00139932]12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) [clinicaltrials:NCT00144196]A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00144326]clinicaltrials:NCT00144339Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma [clinicaltrials:NCT00152984]Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients [clinicaltrials:NCT00157235]Tiotropium / Respimat One-Year Study [clinicaltrials:NCT00168831]clinicaltrials:NCT00168844Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). [clinicaltrials:NCT00239408]A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00239421]A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00239434]Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD [clinicaltrials:NCT00239447]Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD [clinicaltrials:NCT00239460]12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [clinicaltrials:NCT00239473]Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00239499]12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [clinicaltrials:NCT00240435]A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®) [clinicaltrials:NCT00257452]Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders [clinicaltrials:NCT00274014]Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) [clinicaltrials:NCT00274027]Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD [clinicaltrials:NCT00274040]Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva [clinicaltrials:NCT00274066]Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00274092]Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients [clinicaltrials:NCT00274508]Tiotropium (Spiriva) Rehabilitation Study [clinicaltrials:NCT00274521]A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. [clinicaltrials:NCT00274534]Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00274547]A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. [clinicaltrials:NCT00274560]Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity [clinicaltrials:NCT00274573]Spiriva® Assessment of FEV1 (SAFE) [clinicaltrials:NCT00277264]Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00281567]A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00292448]A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD [clinicaltrials:NCT00308191]SERETIDE Plus Tiotropium Versus Individual Components [clinicaltrials:NCT00325169]Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00335621]Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg [clinicaltrials:NCT00350207]A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. [clinicaltrials:NCT00359788]SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00361959]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tiotropium [clinicaltrials_resource:17b37513b438cefbf8247a55601652f1]
Bio2RDF identifier
17b37513b438cefbf8247a55601652f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:17b37513b438cefbf8247a55601652f1
identifier
clinicaltrials_resource:17b37513b438cefbf8247a55601652f1
title
Tiotropium
@en
type
label
Tiotropium [clinicaltrials_resource:17b37513b438cefbf8247a55601652f1]
@en